Aptar Pharma completes first phase of $180M global expansion program

Aptar Pharma completed the first phase of its approximately $180 million expansion program, adding over 23,000 square meters of manufacturing footprint in France and the U.S. to boost capacity for injection system components, including PremiumCoat film-coated components and elastomer components.

“The investments will add new digitalized processes and expand the company’s manufacturing capacity to meet growing customer needs.”healthcarepackaging.com

• 1 source
• healthcarepackaging.comAptar Pharma Completes First Phase of Global Expansion Program | Healthcare PackagingDec 28, 2022

Summarized from public sources; check the original articles before acting on it.